Evidence map›Paper›PMID 30196151›Full record

ArticleBiomaterials2018

A new temperature-dependent strategy to modulate the epidermal growth factor receptor.

Zhe Li, David R Tyrpak, Mincheol Park, Curtis T Okamoto, J Andrew MacKay

Abstract read
In one paragraph

Article in Biomaterials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhe LiDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, USA.
David R TyrpakDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, USA.
Mincheol ParkDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, USA.
Curtis T OkamotoDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, USA.
J Andrew MacKayDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, USA; Department of Biomedical Engineering, University of Southern California, USA; Department of Ophthalmology, University of Southern California, USA. Electronic address: jamackay@usc.edu.

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAPLOWITZ, NEIL · 1995 to 2020
$21.8M
Intracellular switching using genetically engineered protein microdomainsR01GM114839 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MACKAY, JOHN ANDREW · 2015 to 2019
$1.9M
Novel temperature-responsive fusions of clathrin and caveolin to explore TGF-beta mediated fibrosisF31DK118881 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TYRPAK, DAVID RYAN · 2018 to 2019
$77k
NCI NIH HHS P30 CA014089NIDDK NIH HHS F31 DK118881NIDDK NIH HHS P30 DK048522NIGMS NIH HHS R01 GM114839
6 · The paper itself

Abstract

The dynamic manipulation of kinases remains a major obstacle to unraveling cell-signaling networks responsible for the activation of biological systems. For example, epidermal growth factor (EGF) stimulates the epidermal growth factor receptor (EGFR/ErbB1); however, EGF also recruits other kinases (HER2/ErbB2) involved with various signaling pathways. To better study EGFR we report a new strategy to selectively activate receptor tyrosine kinases fused to elastin-like polypeptides (ELPs), which can be visualized inside mammalian cells using fixed and live-cell fluorescence microscopy. ELPs are high molecular weight polypeptides that phase separate abruptly upon heating. When an EGFR-ELP fusion is heated, it clusters, initiates receptor internalization, phosphorylates, initiates downstream kinase signaling, and undergoes retrograde transport towards the cell body. Unlike other strategies to block EGFR (small molecule inhibitors, RNAi, or transcriptional regulators), EGFR-ELP clustering can be specifically switched on or off within minutes. Live-cell imaging suggests that EGFR-ELPs assemble in most cells with only a 3 °C increase in temperature. This strategy was found reversible and able to dynamically control the downstream phosphorylation/activation of the ERK1/2 pathway. For the first time, this strategy enables the rational engineering of specific temperature-sensitive receptors that may have broad applications in the study and manipulation of biological processes.

Indexed as

Cell Line, TumorEpidermal Growth FactorErbB ReceptorsGreen Fluorescent ProteinsHEK293 CellsHumansMicroscopy, FluorescencePeptidesPhosphorylationProtein-Tyrosine KinasesRecombinant Fusion ProteinsTemperatureTransfectionEpidermal Growth FactorErbB ReceptorsGreen Fluorescent ProteinsPeptidesProtein-Tyrosine KinasesRecombinant Fusion Proteins293TElastin-like polypeptidesERK activity dynamicsGreen-fluorescent proteinSynthetic biologyThermo-responsive protein-polymer

Identifiers

PMID30196151
PMCPMC6338443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.